{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:16:02Z","timestamp":1789085762676,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2020.00382","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T13:15:47Z","timestamp":1594905347000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Case Report: Early Treatment With Chenodeoxycholic Acid in Cerebrotendinous Xanthomatosis Presenting as Neonatal Cholestasis"],"prefix":"10.3389","volume":"8","author":[{"given":"Irene","family":"Degrassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Amoruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Del Puppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mignarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Dotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Naturale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Nebbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"B1","first-page":"69","article-title":"Une deuxieme observation de cholesterinose tendineuse symetrique avec symptomes cerebraux","volume":"42","author":"Van Bogaert","year":"1937","journal-title":"Ann Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10545-010-9259-3","article-title":"Disorders of bile acid synthesis","volume":"34","author":"Clayton","year":"2011","journal-title":"J Inherit Metab Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cld.2018.06.006","article-title":"Inborn errors of bile acid metabolism","volume":"22","author":"Heubi","year":"2018","journal-title":"Clin Liver Dis."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-04169-8","article-title":"The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies","author":"Verrips","year":"2019","journal-title":"Neurol Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","article-title":"Pidemiology diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)","volume":"40","author":"Salen","year":"2017","journal-title":"J Inherit Metab Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1023\/A:1021211520034","article-title":"Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis","volume":"25","author":"Clayton","year":"2002","journal-title":"J Inherit Metab Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/MPG.0000000000001730","article-title":"Severe neonatal cholestasis in cerebrotendinous xanthomatosis: genetics, immunostaining, mass spectrometry","volume":"65","author":"Gong","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1542\/peds.2008-0192","article-title":"Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat","volume":"123","author":"Berginer","year":"2009","journal-title":"Pediatrics."},{"key":"B9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13023-016-0419-x","article-title":"Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood","volume":"16","author":"Degos","year":"2016","journal-title":"Orphanet J Rare Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10545-013-9674-3","article-title":"A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis","volume":"37","author":"Mignarri","year":"2014","journal-title":"J Inherit Metab Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/WNF.0b013e318288076a","article-title":"Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis","volume":"36","author":"Yahalom","year":"2013","journal-title":"Clin Neuropharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00415-019-09377-y","article-title":"Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults","volume":"266","author":"Mandia","year":"2019","journal-title":"J Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/nu9101127","article-title":"Nutritional needs, and support for children with chronic liver disease","volume":"9","author":"Yang","year":"2017","journal-title":"Nutrients."},{"key":"B14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10545-015-9873-1","article-title":"Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis","volume":"39","author":"Mignarri","year":"2016","journal-title":"J Inherit Metab Dis."},{"key":"B15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-2275(20)42083-8","article-title":"High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis","volume":"32","author":"Kuriyama","year":"1991","journal-title":"J Lipid Res."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0815-z","article-title":"Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy","volume":"31","author":"Pierre","year":"2008","journal-title":"J Inherit metab Dis."},{"key":"B17","article-title":"A unique case of cerebrotendinous xanthomatosis presenting in infancy with cholestatic liver disease further highlights bile acid synthetic defects as an important category of metabolic liver disease (abstract)","author":"Setchell","year":"2000","journal-title":"Falk Symposium 120. XVI International Bile Acid Meeting"},{"key":"B18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00431-015-2584-7","article-title":"Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment","volume":"175","author":"Huidekoper","year":"2016","journal-title":"Eur J Pediatr."},{"key":"B19","doi-asserted-by":"crossref","first-page":"16637","DOI":"10.1016\/S0021-9258(18)37438-6","article-title":"Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile","volume":"263","author":"Setchell","year":"1988","journal-title":"J Biol Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/01.MPG.0000150419.23031.2A","article-title":"Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy","volume":"40","author":"Von Bahr","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MPG.0000000000001657","article-title":"Oral cholic acid is efficacious and well tolerated in patients with bile acid synthesis and zellweger spectrum disorders","volume":"65","author":"Heubi","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jacl.2018.06.008","article-title":"Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis","volume":"12","author":"Duell","year":"2018","journal-title":"J Clin Lipidol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s004310050818","article-title":"Treatment and follow-up of children with cerebrotendinous xanthomatosis","volume":"157","author":"Van Heijst","year":"1998","journal-title":"Eur J Pediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MPG.0000000000002618","article-title":"Open-label phase 3 continuation study of cholic acid in patients with inborn errors of bile acid synthesis","volume":"70","author":"James","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0009-8981(82)90004-3","article-title":"Serum bile acid profiles in cerebrotendinous xanthomatosis","volume":"118","author":"Beppu","year":"1982","journal-title":"Clin Chim Acta."},{"key":"B26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0006-2944(75)90020-4","article-title":"Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis","volume":"14","author":"Salen","year":"1975","journal-title":"Biochem Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13023-018-0920-5","article-title":"Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood","volume":"13","author":"Gonzales","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archneur.59.4.527","article-title":"Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations","volume":"59","author":"Moghadasian","year":"2002","journal-title":"Arch Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1212\/WNL.0000000000006731","article-title":"Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start","volume":"92","author":"Stelten","year":"2019","journal-title":"Neurology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1194\/jlr.M087999","article-title":"Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment","volume":"59","author":"DeBarber","year":"2018","journal-title":"J Lipid Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1194\/jlr.P075051","article-title":"A newborn screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios","volume":"58","author":"Vaz","year":"2017","journal-title":"J Lipid Res."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2020.00382\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T10:06:13Z","timestamp":1616666773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2020.00382\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":31,"alternative-id":["10.3389\/fped.2020.00382"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.00382","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"article-number":"382"}}